Announced Thu, 25 Jun · 14:59 IST
Trading window closed from July 1 for Q1 FY27 results
Compliance View source PDF
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹2184.90
prior close
₹2159.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.2-0.2-0.5-0.1+0.8-1.4+0.1+1.2+3.3+2.1+0.6——
Up moveDown movePending
AI summary
Glenmark Pharmaceuticals has closed its trading window from July 1, 2026, until it declares unaudited financial results for Q1 ended June 30, 2026, plus 48 hours after. The restriction applies to directors, KMPs, identified employees, their immediate relatives, and connected persons. The board meeting date for the Q1 results announcement will be communicated later. This is a routine compliance requirement under SEBI insider trading rules.
Likely market impact
Routine compliance filing. Signals upcoming Q1 FY27 earnings announcement. No direct impact on shareholders.